JAZZ PHARMACEUTICALS FRANCE

🇫🇷France
Ownership
-
Established
2003-01-01
Employees
-
Market Cap
-
Website
https://www.jazzpharma.com/careers/open-positions/

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

First Posted Date
2014-03-19
Last Posted Date
2022-09-28
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
120
Registration Number
NCT02091375

An Observational Post-Marketing Safety Registry of Sativex®

First Posted Date
2014-02-27
Last Posted Date
2022-12-20
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
978
Registration Number
NCT02073474

A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes

Phase 2
Completed
Conditions
Interventions
First Posted Date
2014-02-03
Last Posted Date
2022-12-20
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
207
Registration Number
NCT02053272
Locations
🇬🇧

Churchill Hospital, Oxford, Oxfordshire, United Kingdom

🇬🇧

Hathaway Surgery, Chippenham, Wiltshire, United Kingdom

🇷🇴

Nicodiab SRL, Bucuresti, Romania

and more 22 locations

A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder

First Posted Date
2013-12-10
Last Posted Date
2022-09-28
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
88
Registration Number
NCT02006628

A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients

Phase 4
Completed
Conditions
Interventions
First Posted Date
2013-10-17
Last Posted Date
2023-01-12
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
121
Registration Number
NCT01964547
Locations
🇨🇿

MS Centre, Charles University, Prague, Czechia

A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-08-08
Last Posted Date
2022-12-20
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
66
Registration Number
NCT01918735
Locations
🇬🇧

Quotient Clinical, Nottingham, United Kingdom

A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years

Phase 3
Completed
Conditions
Interventions
First Posted Date
2013-07-12
Last Posted Date
2022-12-20
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
72
Registration Number
NCT01898520
Locations
🇬🇧

Center 1, London, United Kingdom

🇬🇧

Center 6, Cambridge, United Kingdom

🇨🇿

Center 14, Prague, Czechia

and more 11 locations

Patient Registry of Intrathecal Ziconotide Management(PRIZM)

First Posted Date
2013-06-27
Last Posted Date
2017-03-16
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
93
Registration Number
NCT01888120
Locations
🇺🇸

Clearwater Pain Management, Clearwater, Florida, United States

🇺🇸

Integrated Pain Solutions, Columbus, Ohio, United States

🇺🇸

Desert Pain Institute, Mesa, Arizona, United States

and more 39 locations

Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-06-26
Last Posted Date
2022-12-20
Lead Sponsor
Jazz Pharmaceuticals
Target Recruit Count
32
Registration Number
NCT01887301
Locations
🇺🇸

Anaheim Clinical Trials, LLC, Anaheim, California, United States

🇺🇸

Clinical Pharmacology of Miami, Inc., Miami, Florida, United States

© Copyright 2024. All Rights Reserved by MedPath